Literature DB >> 3997862

Identification of the polymorphonuclear leukocyte C5a receptor.

T E Rollins, M S Springer.   

Abstract

The peptide C5a is thought to play an important role in the inflammatory response primarily through its action on the polymorphonuclear leukocyte (PMN). The receptor for C5a on human PMN has now been identified by affinity labeling. Cross-linking 125I-C5a to intact PMN with disuccinimidyl suberate produced a species that had a molecular mass on sodium dodecyl sulfate gels of 5.2 X 10(4) daltons. We believe this species represents a complex between C5a and its receptor for the following reasons. The band is eliminated if the cross-linking experiment is performed in the presence of a large excess of unlabeled C5a, but is unaffected by the presence of nonspecific protein or the chemotactic factors N-formyl-Met-Leu-Phe and leukotriene B4. The 5.2 X 10(4)-dalton species is not observed if the cross-linker is omitted. Finally, the dose-response curves for the inhibition of binding of 125I-C5a by unlabeled C5a and the inhibition of cross-linking are similar. Subtraction of the molecular mass of C5a from that of the complex gives a molecular mass for the binding moiety of the C5a receptor of 4.0 X 10(4) daltons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997862

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Complement depletion reduces macrophage infiltration and activation during Wallerian degeneration and axonal regeneration.

Authors:  A T Dailey; A M Avellino; L Benthem; J Silver; M Kliot
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

2.  The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.

Authors:  M D Barker; P J Jose; T J Williams; D R Burton
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

Review 3.  Biological properties of human C5a: selected in vitro and in vivo studies.

Authors:  K B Yancey
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

4.  C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes.

Authors:  C Lundberg; F Marceau; T E Hugli
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

5.  Alteration of chemoattractant receptor expression regulates human neutrophil chemotaxis in vivo.

Authors:  Andrew J E Seely; Jean-Francois Naud; Giuseppina Campisi; Betty Giannias; Shuqing Liu; Antonio DiCarlo; Lorenzo E Ferri; Jose L Pascual; Jean Tchervenkov; Nicolas V Christou
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

6.  Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

Authors:  S J Siciliano; T E Rollins; J DeMartino; Z Konteatis; L Malkowitz; G Van Riper; S Bondy; H Rosen; M S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

7.  Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin.

Authors:  J A Ember; S D Sanderson; T E Hugli; E L Morgan
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

8.  Receptor class desensitization of leukocyte chemoattractant receptors.

Authors:  J R Didsbury; R J Uhing; E Tomhave; C Gerard; N Gerard; R Snyderman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

9.  G protein-mediated receptor-receptor interaction: studies with chemotactic receptors in membranes of human leukemia (HL 60) cells.

Authors:  T Wieland; P Gierschik; K H Jakobs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

10.  Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex.

Authors:  T E Rollins; S Siciliano; S Kobayashi; D N Cianciarulo; V Bonilla-Argudo; K Collier; M S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.